{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:34:56Z","timestamp":1794627296362,"version":"4.9.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypertension is a major contributor to the global disease burden, affecting more than one billion individuals worldwide. Despite decades of recognition of its adverse health effects, hypertension control rates remain suboptimal. Epidemiology provides essential knowledge for understanding disease distribution and identifying risk factors at the individual, social, and environmental levels. Recent evidence emphasizes both traditional lifestyle determinants, including excess sodium intake, low potassium intake, obesity, physical inactivity, smoking, and alcohol consumption, and emerging contributors, such as gut microbiota dysregulation and infectious diseases. Among those, the urinary sodium-to-potassium ratio has gained attention as an important factor associated with hypertension risk. Additionally, social determinants of health, including socioeconomic disparities, neighborhood deprivation, and structural racism, exacerbate the risk of hypertension and impede its effective control. Environmental factors such as air pollution, extreme temperatures, and occupational stress further contribute to the complexity of hypertension epidemiology. Regarding contemporary epidemiological methodology, our proposed concepts of the \u201cBench and Real-World Cycle\u201d and \u201cReal-World Evidence Cycle\u201d highlight the necessity of continuously integrating real-world evidence into practice. In addition to classical cohort studies, real-world data derived from electronic health records including health checkups and insurance claims data are indispensable tools for addressing previous research limitations. This multifaceted perspective will accelerate evidence-based epidemiological approaches for preventing and treating hypertension.<\/jats:p>","DOI":"10.1038\/s41440-025-02532-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:27:22Z","timestamp":1767947242000},"page":"756-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Current hypertension epidemiology and contemporary approaches using the \u201cReal-World Evidence Cycle\u201d framework"],"prefix":"10.1038","volume":"49","author":[{"given":"Michihiro","family":"Satoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Iwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Metoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD Risk Factors Collaborators","year":"2024","unstructured":"GBD Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2162\u2013203.","journal-title":"Lancet"},{"key":"2532_CR2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","volume":"371","author":"CM Lawes","year":"2008","unstructured":"Lawes CM, Vander Hoorn S, Rodgers A. International Society of H. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513\u20138.","journal-title":"Lancet"},{"key":"2532_CR3","doi-asserted-by":"crossref","unstructured":"Ohya Y, Sakima A, Arima H, Fukami A, Furuhashi M, Ishida M, et al. Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025). Hypertens Res. 2025;48:2500\u201311.","DOI":"10.1038\/s41440-025-02331-8"},{"key":"2532_CR4","unstructured":"Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;82:e212\u2013316."},{"key":"2532_CR5","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912\u20134018.","journal-title":"Eur Heart J"},{"key":"2532_CR6","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"2532_CR7","first-page":"225","volume":"38","author":"TD Wang","year":"2022","unstructured":"Wang TD, Chiang CE, Chao TH, Cheng HM, Wu YW, Wu YJ, et al. 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension. Acta Cardiol Sin. 2022;38:225\u2013325.","journal-title":"Acta Cardiol Sin"},{"key":"2532_CR8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2532_CR9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration","year":"2021","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957\u201380.","journal-title":"Lancet"},{"key":"2532_CR10","doi-asserted-by":"crossref","unstructured":"Hisamatsu T, Miura K. Epidemiology and control of hypertension in Japan: a comparison with Western countries. J Hum Hypertens. 2024;38:469\u201376.","DOI":"10.1038\/s41371-021-00534-3"},{"key":"2532_CR11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41440-020-0508-z","volume":"43","author":"T Hisamatsu","year":"2020","unstructured":"Hisamatsu T, Segawa H, Kadota A, Ohkubo T, Arima H, Miura K. Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines. Hypertens Res. 2020;43:1344\u201351.","journal-title":"Hypertens Res"},{"key":"2532_CR12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41440-019-0220-z","volume":"42","author":"A Harada","year":"2019","unstructured":"Harada A, Ueshima H, Kinoshita Y, Miura K, Ohkubo T, Asayama K, et al. Absolute risk score for stroke, myocardial infarction, and all cardiovascular disease: Japan Arteriosclerosis Longitudinal Study. Hypertens Res. 2019;42:567\u201379.","journal-title":"Hypertens Res"},{"key":"2532_CR13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41440-025-02151-w","volume":"48","author":"M Satoh","year":"2025","unstructured":"Satoh M, Ohkubo T, Miura K, Harada A, Tsutsui A, Hozawa A, et al. Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guideline. Hypertens Res. 2025;48:1428\u201333.","journal-title":"Hypertens Res"},{"key":"2532_CR14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41440-024-01653-3","volume":"47","author":"K Kuwahara","year":"2024","unstructured":"Kuwahara K, Ohkubo T, Inoue Y, Honda T, Yamamoto S, Nakagawa T, et al. Blood pressure classification using the Japanese Society of Hypertension Guidelines for the Management of Hypertension and cardiovascular events among young to middle-aged working adults. Hypertens Res. 2024;47:1861\u201370.","journal-title":"Hypertens Res"},{"key":"2532_CR15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","volume":"393","author":"C Global Cardiovascular Risk","year":"2025","unstructured":"Global Cardiovascular Risk C, Magnussen C, Alegre-Diaz J, Al-Nasser LA, Amouyel P, Aviles-Santa L, et al. Global Effect of Cardiovascular Risk Factors on Lifetime Estimates. N Engl J Med. 2025;393:125\u201338.","journal-title":"N Engl J Med"},{"key":"2532_CR16","first-page":"e41","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025;151:e41\u2013e660.","journal-title":"Circulation"},{"key":"2532_CR17","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/s41440-024-01853-x","volume":"47","author":"P Marques-Vidal","year":"2024","unstructured":"Marques-Vidal P, Maung KK, Gouveia A. Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland. Hypertens Res. 2024;47:2847\u201354.","journal-title":"Hypertens Res"},{"key":"2532_CR18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1495::AID-SIM441>3.0.CO;2-E","volume":"19","author":"A Beiser","year":"2000","unstructured":"Beiser A, D\u2019Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Computing estimates of incidence, including lifetime risk: Alzheimer\u2019s disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med. 2000;19:1495\u2013522.","journal-title":"Stat Med"},{"key":"2532_CR19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/HYPERTENSIONAHA.118.11635","volume":"73","author":"M Satoh","year":"2019","unstructured":"Satoh M, Ohkubo T, Asayama K, Murakami Y, Sugiyama D, Yamada M, et al. Lifetime Risk of Stroke and Coronary Heart Disease Deaths According to Blood Pressure Level: EPOCH-JAPAN (Evidence for Cardiovascular Prevention From Observational Cohorts in Japan). Hypertension. 2019;73:52\u201359.","journal-title":"Hypertension"},{"key":"2532_CR20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41440-020-0502-5","volume":"43","author":"Y Imai","year":"2020","unstructured":"Imai Y, Hirata T, Saitoh S, Ninomiya T, Miyamoto Y, Ohnishi H, et al. Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study. Hypertens Res. 2020;43:1437\u201344.","journal-title":"Hypertens Res"},{"key":"2532_CR21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41440-021-00635-z","volume":"44","author":"S Nakayama","year":"2021","unstructured":"Nakayama S, Satoh M, Metoki H, Murakami T, Asayama K, Hara A, et al. Lifetime risk of stroke stratified by chronic kidney disease and hypertension in the general Asian population: the Ohasama study. Hypertens Res. 2021;44:866\u201373.","journal-title":"Hypertens Res"},{"key":"2532_CR22","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1038\/s41440-024-01861-x","volume":"47","author":"T Hisamatsu","year":"2024","unstructured":"Hisamatsu T, Kogure M, Tabara Y, Hozawa A, Sakima A, Tsuchihashi T, et al. Practical use and target value of urine sodium-to-potassium ratio in assessment of hypertension risk for Japanese: Consensus Statement by the Japanese Society of Hypertension Working Group on Urine Sodium-to-Potassium Ratio. Hypertens Res. 2024;47:3288\u2013302.","journal-title":"Hypertens Res"},{"key":"2532_CR23","doi-asserted-by":"crossref","unstructured":"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24\u2009h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297:319-28.","DOI":"10.1136\/bmj.297.6644.319"},{"key":"2532_CR24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3945\/an.114.006783","volume":"5","author":"V Perez","year":"2014","unstructured":"Perez V, Chang ET. Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr. 2014;5:712\u201341.","journal-title":"Adv Nutr"},{"key":"2532_CR25","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/HJH.0000000000002802","volume":"39","author":"T Hisamatsu","year":"2021","unstructured":"Hisamatsu T, Lloyd-Jones DM, Colangelo LA, Liu K. Urinary sodium and potassium excretions in young adulthood and blood pressure by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Hypertens. 2021;39:1586\u201393.","journal-title":"J Hypertens"},{"key":"2532_CR26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41440-018-0152-z","volume":"42","author":"T Thi Minh Nguyen","year":"2019","unstructured":"Thi Minh Nguyen T, Miura K, Tanaka-Mizuno S, Tanaka T, Nakamura Y, Fujiyoshi A, et al. Association of blood pressure with estimates of 24-h urinary sodium and potassium excretion from repeated single-spot urine samples. Hypertens Res. 2019;42:411\u20138.","journal-title":"Hypertens Res"},{"key":"2532_CR27","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1097\/HJH.0000000000000734","volume":"33","author":"Y Tabara","year":"2015","unstructured":"Tabara Y, Takahashi Y, Kumagai K, Setoh K, Kawaguchi T, Takahashi M, et al. Descriptive epidemiology of spot urine sodium-to-potassium ratio clarified close relationship with blood pressure level: the Nagahama study. J Hypertens. 2015;33:2407\u201313.","journal-title":"J Hypertens"},{"key":"2532_CR28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/HYPERTENSIONAHA.117.09928","volume":"71","author":"J Stamler","year":"2018","unstructured":"Stamler J, Chan Q, Daviglus ML, Dyer AR, Van Horn L, Garside DB, et al. Relation of Dietary Sodium (Salt) to Blood Pressure and Its Possible Modulation by Other Dietary Factors: The INTERMAP Study. Hypertension. 2018;71:631\u20137.","journal-title":"Hypertension"},{"key":"2532_CR29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/HJH.0000000000003087","volume":"40","author":"T Muroya","year":"2022","unstructured":"Muroya T, Satoh M, Murakami T, Nakayama S, Asayama K, Hirose T, et al. Association between urinary sodium-to-potassium ratio and home blood pressure and ambulatory blood pressure: the Ohasama study. J Hypertens. 2022;40:862\u20139.","journal-title":"J Hypertens"},{"key":"2532_CR30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archinternmed.2008.523","volume":"169","author":"NR Cook","year":"2009","unstructured":"Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med. 2009;169:32\u201340.","journal-title":"Arch Intern Med"},{"key":"2532_CR31","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1038\/s41440-025-02266-0","volume":"48","author":"T Muroya","year":"2025","unstructured":"Muroya T, Satoh M, Metoki H, Nakayama S, Hirose T, Murakami T, et al. Association between urinary sodium-to-potassium ratio and BNP in a general population without antihypertensive treatment and cardiovascular diseases: the Ohasama study. Hypertens Res. 2025;48:2292\u2013302.","journal-title":"Hypertens Res"},{"key":"2532_CR32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2109794","volume":"386","author":"Y Ma","year":"2022","unstructured":"Ma Y, He FJ, Sun Q, Yuan C, Kieneker LM, Curhan GC, et al. 24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. N Engl J Med. 2022;386:252\u201363.","journal-title":"N Engl J Med"},{"key":"2532_CR33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","volume":"385","author":"B Neal","year":"2021","unstructured":"Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of Salt Substitution on Cardiovascular Events and Death. N Engl J Med. 2021;385:1067\u201377.","journal-title":"N Engl J Med"},{"key":"2532_CR34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ajh\/hpu115","volume":"28","author":"M Satoh","year":"2015","unstructured":"Satoh M, Kikuya M, Hosaka M, Asayama K, Inoue R, Metoki H, et al. Association of aldosterone-to-renin ratio with hypertension differs by sodium intake: the Ohasama study. Am J Hypertens. 2015;28:208\u201315.","journal-title":"Am J Hypertens"},{"key":"2532_CR35","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1097\/HJH.0b013e32834ab46a","volume":"29","author":"M Satoh","year":"2011","unstructured":"Satoh M, Kikuya M, Ohkubo T, Mori T, Metoki H, Hashimoto T, et al. Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama study. J Hypertens. 2011;29:1940\u20137.","journal-title":"J Hypertens"},{"key":"2532_CR36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ajh.2012.33","volume":"25","author":"M Satoh","year":"2012","unstructured":"Satoh M, Kikuya M, Ohkubo T, Mori T, Metoki H, Hara A, et al. Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake: the Ohasama study. Am J Hypertens. 2012;25:777\u201383.","journal-title":"Am J Hypertens"},{"key":"2532_CR37","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1161\/HYPERTENSIONAHA.112.195230","volume":"59","author":"M Satoh","year":"2012","unstructured":"Satoh M, Kikuya M, Ohkubo T, Imai Y. Role of angiotensinogen and relative aldosterone excess in salt-sensitive hypertension. Hypertension. 2012;59:e57.","journal-title":"Hypertension"},{"key":"2532_CR38","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ajh.2011.235","volume":"25","author":"M Satoh","year":"2012","unstructured":"Satoh M, Kikuya M, Ohkubo T, Imai Y. Role of relative aldosterone excess in salt-sensitive hypertension among African ancestry. Am J Hypertens. 2012;25:398\u20139.","journal-title":"Am J Hypertens"},{"key":"2532_CR39","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/hr.2010.236","volume":"34","author":"M Satoh","year":"2011","unstructured":"Satoh M, Kikuya M, Hara A, Ohkubo T, Mori T, Metoki H, et al. Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study. Hypertens Res. 2011;34:361\u20136.","journal-title":"Hypertens Res"},{"key":"2532_CR40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/10641963.2014.892121","volume":"36","author":"M Satoh","year":"2014","unstructured":"Satoh M, Hosaka M, Asayama K, Kikuya M, Inoue R, Metoki H, et al. Aldosterone-to-renin ratio and nocturnal blood pressure decline assessed by self-measurement of blood pressure at home: the Ohasama Study. Clin Exp Hypertens. 2014;36:108\u201314.","journal-title":"Clin Exp Hypertens"},{"key":"2532_CR41","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41440-022-00948-7","volume":"45","author":"M Yoon","year":"2022","unstructured":"Yoon M, Hong N, Ha J, Lee CJ, Ku CR, Rhee Y, et al. Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea. Hypertens Res. 2022;45:1418\u201329.","journal-title":"Hypertens Res"},{"key":"2532_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","volume":"34","author":"Y Ito","year":"2011","unstructured":"Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res. 2011;34:98\u2013102.","journal-title":"Hypertens Res"},{"key":"2532_CR43","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary Aldosteronism in Patients in China With Recently Detected Hypertension. J Am Coll Cardiol. 2020;75:1913\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"2532_CR44","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/HYPERTENSIONAHA.124.21721","volume":"81","author":"DJ Durgan","year":"2024","unstructured":"Durgan DJ, Zubcevic J, Vijay-Kumar M, Yang T, Manandhar I, Aryal S, et al. Prospects for Leveraging the Microbiota as Medicine for Hypertension. Hypertension. 2024;81:951\u201363.","journal-title":"Hypertension"},{"key":"2532_CR45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11906-022-01216-2","volume":"24","author":"C Xu","year":"2022","unstructured":"Xu C, Marques FZ. How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure. Curr Hypertens Rep. 2022;24:509\u201321.","journal-title":"Curr Hypertens Rep"},{"key":"2532_CR46","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.122.20752","volume":"80","author":"PD Virwani","year":"2023","unstructured":"Virwani PD, Qian G, Hsu MSS, Pijarnvanit T, Cheung CN, Chow YH, et al. Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring. Hypertension. 2023;80:1331\u201342.","journal-title":"Hypertension"},{"key":"2532_CR47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HJH.0000000000003716","volume":"42","author":"J Guo","year":"2024","unstructured":"Guo J, Jia P, Gu Z, Tang W, Wang A, Sun Y, et al. Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension. J Hypertens. 2024;42:1212\u201325.","journal-title":"J Hypertens"},{"key":"2532_CR48","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41440-023-01334-7","volume":"46","author":"R Mizoguchi","year":"2023","unstructured":"Mizoguchi R, Karashima S, Miyajima Y, Ogura K, Kometani M, Aono D, et al. Impact of gut microbiome on the renin-aldosterone system: Shika-machi Super Preventive Health Examination results. Hypertens Res. 2023;46:2280\u201392.","journal-title":"Hypertens Res"},{"key":"2532_CR49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41440-023-01435-3","volume":"47","author":"T Kubozono","year":"2024","unstructured":"Kubozono T, Akasaki Y, Kawasoe S, Ojima S, Yamaguchi S, Kuwahata S, et al. Relationship between defecation status and blood pressure level or blood pressure variability. Hypertens Res. 2024;47:128\u201336.","journal-title":"Hypertens Res"},{"key":"2532_CR50","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/HYPERTENSIONAHA.123.21174","volume":"80","author":"V Zhang","year":"2023","unstructured":"Zhang V, Fisher M, Hou W, Zhang L, Duong TQ. Incidence of New-Onset Hypertension Post-COVID-19: Comparison With Influenza. Hypertension. 2023;80:2135\u201348.","journal-title":"Hypertension"},{"key":"2532_CR51","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/HYPERTENSIONAHA.122.19958","volume":"80","author":"D Faria","year":"2023","unstructured":"Faria D, Moll-Bernardes RJ, Testa L, Moniz CMV, Rodrigues EC, Rodrigues AG, et al. Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae. Hypertension. 2023;80:470\u201381.","journal-title":"Hypertension"},{"key":"2532_CR52","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41440-024-02000-2","volume":"48","author":"HK Park","year":"2025","unstructured":"Park HK, Shim YS. Hypertension prevalence in Korean adolescents according to parental hypertension: data from the Korea National Health and Nutrition Survey. Hypertens Res. 2025;48:1003\u201311.","journal-title":"Hypertens Res"},{"key":"2532_CR53","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCULATIONAHA.117.030898","volume":"137","author":"R Pazoki","year":"2018","unstructured":"Pazoki R, Dehghan A, Evangelou E, Warren H, Gao H, Caulfield M, et al. Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events. Circulation. 2018;137:653\u201361.","journal-title":"Circulation"},{"key":"2532_CR54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","volume":"3","author":"MA Said","year":"2018","unstructured":"Said MA, Verweij N, van der Harst P. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study. JAMA Cardiol. 2018;3:693\u2013702.","journal-title":"JAMA Cardiol"},{"key":"2532_CR55","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/HYPERTENSIONAHA.120.16471","volume":"77","author":"F Vaura","year":"2021","unstructured":"Vaura F, Kauko A, Suvila K, Havulinna AS, Mars N, Salomaa V, et al. Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk. Hypertension. 2021;77:1119\u201327.","journal-title":"Hypertension"},{"key":"2532_CR56","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31080-2","volume":"13","author":"N Kurniansyah","year":"2022","unstructured":"Kurniansyah N, Goodman MO, Kelly TN, Elfassy T, Wiggins KL, Bis JC, et al. A multi-ethnic polygenic risk score is associated with hypertension prevalence and progression throughout adulthood. Nat Commun. 2022;13:3549.","journal-title":"Nat Commun"},{"key":"2532_CR57","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1038\/s41440-025-02314-9","volume":"48","author":"M Takase","year":"2025","unstructured":"Takase M, Hirata T, Nakaya N, Kogure M, Hatanaka R, Nakaya K, et al. Associations of family history of hypertension, genetic, and lifestyle risks with incident hypertension. Hypertens Res. 2025;48:2606\u201317.","journal-title":"Hypertens Res."},{"key":"2532_CR58","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41440-024-01705-8","volume":"47","author":"M Takase","year":"2024","unstructured":"Takase M, Hirata T, Nakaya N, Nakamura T, Kogure M, Hatanaka R, et al. Associations of combined genetic and lifestyle risks with hypertension and home hypertension. Hypertens Res. 2024;47:2064\u201374.","journal-title":"Hypertens Res"},{"key":"2532_CR59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.puhe.2021.08.009","volume":"199","author":"G Dahlgren","year":"2021","unstructured":"Dahlgren G, Whitehead M. The Dahlgren-Whitehead model of health determinants: 30 years on and still chasing rainbows. Public Health. 2021;199:20\u201324.","journal-title":"Public Health"},{"key":"2532_CR60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","volume":"15","author":"KR McLeroy","year":"1988","unstructured":"McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15:351\u201377.","journal-title":"Health Educ Q"},{"key":"2532_CR61","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/s41440-024-01615-9","volume":"47","author":"J Aida","year":"2024","unstructured":"Aida J, Inoue Y, Tabuchi T, Kondo N. Modifiable risk factors of inequalities in hypertension: analysis of 100 million health checkups recipients. Hypertens Res. 2024;47:1555\u201366.","journal-title":"Hypertens Res"},{"key":"2532_CR62","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/HYPERTENSIONAHA.123.22055","volume":"81","author":"CA Rivier","year":"2024","unstructured":"Rivier CA, Renedo DB, Sunmonu NA, de Havenon A, Sheth KN, Falcone GJ. Neighborhood Deprivation, Race, Ethnicity, and Undiagnosed Hypertension: Results From the All of Us Research Program. Hypertension. 2024;81:e10\u2013e12.","journal-title":"Hypertension"},{"key":"2532_CR63","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.122.20219","volume":"80","author":"OP Akinyelure","year":"2023","unstructured":"Akinyelure OP, Jaeger BC, Oparil S, Carson AP, Safford MM, Howard G, et al. Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. Hypertension. 2023;80:1403\u201313.","journal-title":"Hypertension"},{"key":"2532_CR64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/HYPERTENSIONAHA.124.23772","volume":"82","author":"T Janevic","year":"2025","unstructured":"Janevic T, Howell FM, Burdick M, Nowlin S, Maru S, Boychuk N, et al. Racism and Postpartum Blood Pressure in a Multiethnic Prospective Cohort. Hypertension. 2025;82:206\u201315.","journal-title":"Hypertension"},{"key":"2532_CR65","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1161\/CIR.0000000000001203","volume":"149","author":"MA Albert","year":"2024","unstructured":"Albert MA, Churchwell K, Desai N, Johnson JC, Johnson MN, Khera A, et al. Addressing Structural Racism Through Public Policy Advocacy: A Policy Statement From the American Heart Association. Circulation. 2024;149:e312\u201329.","journal-title":"Circulation"},{"key":"2532_CR66","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41440-022-00961-w","volume":"45","author":"M Satoh","year":"2022","unstructured":"Satoh M, Murakami T, Obara T, Metoki H. Time-series analysis of blood pressure changes after the guideline update in 2019 and the coronavirus disease pandemic in 2020 using Japanese longitudinal data. Hypertens Res. 2022;45:1408\u201317.","journal-title":"Hypertens Res"},{"key":"2532_CR67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.121.057075","volume":"145","author":"LJ Laffin","year":"2022","unstructured":"Laffin LJ, Kaufman HW, Chen Z, Niles JK, Arellano AR, Bare LA, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022;145:235\u20137.","journal-title":"Circulation"},{"key":"2532_CR68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41440-024-02067-x","volume":"48","author":"M Toyama","year":"2025","unstructured":"Toyama M, Satoh M, Hashimoto H, Iwabe Y, Yagihashi T, Nakayama S, et al. Association between equivalized annual household income and regular medical visits for hypertensive patients since the COVID-19 outbreak. Hypertens Res. 2025;48:786\u201395.","journal-title":"Hypertens Res"},{"key":"2532_CR69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCULATIONAHA.125.073086","volume":"152","author":"S Lee","year":"2025","unstructured":"Lee S, Hwang SH, Park S, Son Y, Kim S, Kim HJ, et al. Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study. Circulation. 2025;152:11\u201323.","journal-title":"Circulation"},{"key":"2532_CR70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.122.061832","volume":"147","author":"B Alahmad","year":"2023","unstructured":"Alahmad B, Khraishah H, Roye D, Vicedo-Cabrera AM, Guo Y, Papatheodorou SI, et al. Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries. Circulation. 2023;147:35\u201346.","journal-title":"Circulation"},{"key":"2532_CR71","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/HJH.0000000000003795","volume":"42","author":"S Dong","year":"2024","unstructured":"Dong S, Yu B, Yin C, Li Y, Zhong W, Feng C, et al. Associations between PM 2.5 and its chemical constituents and blood pressure: a cross-sectional study. J Hypertens. 2024;42:1897\u2013905.","journal-title":"J Hypertens"},{"key":"2532_CR72","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/HYPERTENSIONAHA.123.21410","volume":"80","author":"T Wang","year":"2023","unstructured":"Wang T, Han Y, Chen X, Chen W, Li H, Wang Y, et al. Particulate Air Pollution and Blood Pressure: Signaling by the Arachidonate Metabolism. Hypertension. 2023;80:2687\u201396.","journal-title":"Hypertension"},{"key":"2532_CR73","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.123.20617","volume":"80","author":"O Hahad","year":"2023","unstructured":"Hahad O, Rajagopalan S, Lelieveld J, Sorensen M, Kuntic M, Daiber A, et al. Noise and Air Pollution as Risk Factors for Hypertension: Part II-Pathophysiologic Insight. Hypertension. 2023;80:1384\u201392.","journal-title":"Hypertension"},{"key":"2532_CR74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/HJH.0000000000003878","volume":"43","author":"X Zheng","year":"2025","unstructured":"Zheng X, Zou P, Zeng C, Liu J, He Y. Increased levels of urine volatile organic compounds are associated with hypertension risk. J Hypertens. 2025;43:136\u201344.","journal-title":"J Hypertens"},{"key":"2532_CR75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.124.23695","volume":"82","author":"KE McGraw","year":"2025","unstructured":"McGraw KE, Domingo-Relloso A, Riggs DW, Medgyesi DN, Neupane R, Stingone JA, et al. Exposure to Volatile Organic Compounds and Blood Pressure in NHANES 2011 to 2018. Hypertension. 2025;82:136\u201348.","journal-title":"Hypertension"},{"key":"2532_CR76","doi-asserted-by":"crossref","first-page":"e1165","DOI":"10.1161\/CIR.0000000000001234","volume":"149","author":"JP Zachariah","year":"2024","unstructured":"Zachariah JP, Jone PN, Agbaje AO, Ryan HH, Trasande L, Perng W, et al. Environmental Exposures and Pediatric Cardiology: A Scientific Statement From the American Heart Association. Circulation. 2024;149:e1165\u201375.","journal-title":"Circulation"},{"key":"2532_CR77","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1161\/HYPERTENSIONAHA.111.184077","volume":"58","author":"M Satoh","year":"2011","unstructured":"Satoh M, Kikuya M, Ohkubo T, Imai Y. Acute and subacute effects of the great East Japan earthquake on home blood pressure values. Hypertension. 2011;58:e193\u20134.","journal-title":"Hypertension"},{"key":"2532_CR78","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajh\/hpv044","volume":"28","author":"M Nishizawa","year":"2015","unstructured":"Nishizawa M, Hoshide S, Okawara Y, Shimpo M, Matsuo T, Kario K. Aftershock Triggers Augmented Pressor Effects in Survivors: Follow-Up of the Great East Japan Earthquake. Am J Hypertens. 2015;28:1405\u20138.","journal-title":"Am J Hypertens"},{"key":"2532_CR79","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/HYPERTENSIONAHA.116.07499","volume":"68","author":"T Ohira","year":"2016","unstructured":"Ohira T, Hosoya M, Yasumura S, Satoh H, Suzuki H, Sakai A, et al. Evacuation and Risk of Hypertension After the Great East Japan Earthquake: The Fukushima Health Management Survey. Hypertension. 2016;68:558\u201364.","journal-title":"Hypertension"},{"key":"2532_CR80","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jch.13500","volume":"21","author":"RD Brook","year":"2019","unstructured":"Brook RD, Brook JR, Tam EK. Volcanic smog and cardiometabolic health: Hawaiian hypertension?. J Clin Hypertens. 2019;21:533\u20135.","journal-title":"J Clin Hypertens"},{"key":"2532_CR81","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/HJH.0000000000003619","volume":"42","author":"S Karelius","year":"2024","unstructured":"Karelius S, Pentti J, Juhanoja E, Jula A, Koskinen S, Niiranen TJ, et al. Association of work-related psychosocial factors and day-to-day home blood pressure variation: the Finn-Home study. J Hypertens. 2024;42:337\u201343.","journal-title":"J Hypertens"},{"key":"2532_CR82","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/s41440-023-01360-5","volume":"46","author":"N Nakamura","year":"2023","unstructured":"Nakamura N, Akiyama H, Nishimura M, Zhu K, Suzuki K, Higuchi M, et al. Acute social jetlag augments morning blood pressure surge: a randomized crossover trial. Hypertens Res. 2023;46:2179\u201391.","journal-title":"Hypertens Res"},{"key":"2532_CR83","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41440-023-01452-2","volume":"47","author":"M Satoh","year":"2024","unstructured":"Satoh M, Muroya T, Murakami T, Obara T, Asayama K, Ohkubo T, et al. The impact of clinical inertia on uncontrolled blood pressure in treated hypertension: real-world, longitudinal data from Japan. Hypertens Res. 2024;47:598\u2013607.","journal-title":"Hypertens Res"},{"key":"2532_CR84","doi-asserted-by":"crossref","unstructured":"Fujishima S, Kodama S, Tsuchihashi T. Achievement rate of blood pressure <140\/90 mmHg and <130\/80 mmHg in subjects with hypertension; findings from a Japanese health checkup in 2017. Clin Exp Hypertens. 2020;42:648\u201355.","DOI":"10.1080\/10641963.2020.1764017"},{"key":"2532_CR85","doi-asserted-by":"crossref","first-page":"300060522112687","DOI":"10.1177\/03000605221126878","volume":"50","author":"H Yokokawa","year":"2022","unstructured":"Yokokawa H, Suzuki M, Aoki N, Sato Y, Naito T. Achievement of target blood pressure among community residents with hypertension and factors associated with therapeutic failure in the northern territory of Japan. J Int Med Res. 2022;50:3000605221126878.","journal-title":"J Int Med Res"},{"key":"2532_CR86","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10641963.2020.1867158","volume":"43","author":"K Ohno","year":"2021","unstructured":"Ohno K, Takase H, Sugiura T, Machii M, Nonaka D, Tokumaru M, et al. Current status and recent changes in blood pressure and dietary salt consumption in Japanese individuals. Clin Exp Hypertens. 2021;43:287\u201394.","journal-title":"Clin Exp Hypertens"},{"key":"2532_CR87","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41440-023-01362-3","volume":"46","author":"A Sakima","year":"2023","unstructured":"Sakima A, Yamazato M, Kohagura K, Ishida A, Matayoshi T, Tana T, et al. Achievement rate of target blood pressure in patients with hypertension treated by hypertension specialists and non-specialists in a real-world setting. Hypertens Res. 2023;46:2460\u20139.","journal-title":"Hypertens Res"},{"key":"2532_CR88","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","volume":"135","author":"LS Phillips","year":"2001","unstructured":"Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135:825\u201334.","journal-title":"Ann Intern Med"},{"key":"2532_CR89","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/HJH.0000000000002783","volume":"39","author":"DH Ali","year":"2021","unstructured":"Ali DH, Kilic B, Hart HE, Bots ML, Biermans MCJ, Spiering W, et al. Therapeutic inertia in the management of hypertension in primary care. J Hypertens. 2021;39:1238\u201345.","journal-title":"J Hypertens"},{"key":"2532_CR90","doi-asserted-by":"publisher","unstructured":"Iwabe Y, Satoh M, Nobayashi H, Izumi S, Murakami T, Toyama M, et al. Regional disparities in blood pressure control after hypertension treatment initiation in Japan: a real-world data analysis. Hypertens Res. 2025; https:\/\/doi.org\/10.1038\/s41440-025-02454-y.","DOI":"10.1038\/s41440-025-02454-y"},{"key":"2532_CR91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41440-024-01954-7","volume":"48","author":"M Satoh","year":"2025","unstructured":"Satoh M, Metoki H, Murakami T, Tatsumi Y, Asayama K, Kikuya M, et al. Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study. Hypertens Res. 2025;48:26\u201336.","journal-title":"Hypertens Res"},{"key":"2532_CR92","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41440-022-01011-1","volume":"45","author":"Y Imai","year":"2022","unstructured":"Imai Y. A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements. Hypertens Res. 2022;45:1726\u201342.","journal-title":"Hypertens Res"},{"key":"2532_CR93","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41440-024-01981-4","volume":"48","author":"M Satoh","year":"2025","unstructured":"Satoh M, Tatsumi Y, Nakayama S, Shinohara Y, Kawazoe M, Nozato Y, et al. Self-measurement of blood pressure at home using a cuff device for change in blood pressure levels: systematic review and meta-analysis. Hypertens Res. 2025;48:574\u201391.","journal-title":"Hypertens Res"},{"key":"2532_CR94","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/01.hjh.0000234105.23615.95","volume":"24","author":"A Hozawa","year":"2006","unstructured":"Hozawa A, Shimazu T, Kuriyama S, Tsuji I. Benefit of home blood pressure measurement after a finding of high blood pressure at a community screening. J Hypertens. 2006;24:1265\u201371.","journal-title":"J Hypertens"},{"key":"2532_CR95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ajh\/hpz182","volume":"33","author":"JP Sheppard","year":"2020","unstructured":"Sheppard JP, Tucker KL, Davison WJ, Stevens R, Aekplakorn W, Bosworth HB, et al. Self-monitoring of Blood Pressure in Patients With Hypertension-Related Multi-morbidity: Systematic Review and Individual Patient Data Meta-analysis. Am J Hypertens. 2020;33:243\u201351.","journal-title":"Am J Hypertens"},{"key":"2532_CR96","doi-asserted-by":"crossref","first-page":"m4858","DOI":"10.1136\/bmj.m4858","volume":"372","author":"RJ McManus","year":"2021","unstructured":"McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ. 2021;372:m4858.","journal-title":"BMJ"},{"key":"2532_CR97","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003827","volume":"42","author":"K Kario","year":"2024","unstructured":"Kario K, Williams B, Tomitani N, McManus RJ, Schutte AE, Avolio A, et al. Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin American Society of Hypertension. J Hypertens. 2024;42:1874\u201388.","journal-title":"J Hypertens"},{"key":"2532_CR98","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jama.2021.24464","volume":"327","author":"DS Picone","year":"2022","unstructured":"Picone DS, Campbell NRC, Schutte AE, Olsen MH, Ordunez P, Whelton PK, et al. Validation Status of Blood Pressure Measuring Devices Sold Globally. JAMA. 2022;327:680\u20131.","journal-title":"JAMA"},{"key":"2532_CR99","doi-asserted-by":"crossref","unstructured":"Kario K, Asayama K, Arima H, Matsumoto C, Nakagawa N, Nomura A, et al. Digital hypertension \u2013 what we need for the high-quality management of hypertension in the new era. Hypertns Res. 2025;48:3130\u201346.","DOI":"10.1038\/s41440-025-02307-8"},{"key":"2532_CR100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41440-024-01925-y","volume":"48","author":"YS Lin","year":"2025","unstructured":"Lin YS, Lin HJ, Wang TD. Physicians\u2019 knowledge, awareness and instructions of home blood pressure monitoring: Asia HBPM survey in Taiwan. Hypertens Res. 2025;48:60\u20137.","journal-title":"Hypertens Res"},{"key":"2532_CR101","doi-asserted-by":"crossref","unstructured":"Satoh M. Understanding clinical inertia in hypertension management: clues from real-world data. Hypertens Res. 2025;48:3046\u20138.","DOI":"10.1038\/s41440-025-02359-w"},{"key":"2532_CR102","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010396","volume":"17","author":"KT Mills","year":"2024","unstructured":"Mills KT, O\u2019Connell SS, Pan M, Obst KM, He H, He J. Role of Health Care Professionals in the Success of Blood Pressure Control Interventions in Patients With Hypertension: A Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2024;17:e010396.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2532_CR103","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/s41440-025-02152-9","volume":"48","author":"Y Akasaki","year":"2025","unstructured":"Akasaki Y, Suematsu Y, Azushima K, Shiga Y, Sakima A, Satoh M, et al. Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis. Hypertens Res. 2025;48:1827\u201338.","journal-title":"Hypertens Res"},{"key":"2532_CR104","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(22)02603-4","volume":"401","author":"J He","year":"2023","unstructured":"He J, Ouyang N, Guo X, Sun G, Li Z, Mu J, et al. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial. Lancet. 2023;401:928\u201338.","journal-title":"Lancet"},{"key":"2532_CR105","unstructured":"Food and Drug Administration (United States). Framework for FDA\u2019S Real-world Evidence Program. 2018. https:\/\/www.fda.gov\/media\/120060\/download. Accessed 05\/Jan\/2026."},{"key":"2532_CR106","unstructured":"National Institute for Health and Clinical Excellence (United Kingdom). NICE real-world evidence framework, Corporate document Reference number:ECD9. 2022. https:\/\/www.nice.org.uk\/corporate\/ecd9\/chapter\/methods-for-real-world-studies-of-comparative-effects. Accessed 05\/Jan\/2026."},{"key":"2532_CR107","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1038\/s41440-024-01875-5","volume":"47","author":"M Satoh","year":"2024","unstructured":"Satoh M, Nakayama S, Toyama M, Hashimoto H, Murakami T, Metoki H. Usefulness and caveats of real-world data for research on hypertension and its association with cardiovascular or renal disease in Japan. Hypertens Res. 2024;47:3099\u2013113.","journal-title":"Hypertens Res"},{"key":"2532_CR108","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jacl.2024.12.006","volume":"19","author":"M Satoh","year":"2025","unstructured":"Satoh M, Nakayama S, Hashimoto H, Toyama M, Iwabe Y, Yagihashi T, et al. Differential coronary heart disease risk among antihypertensive and lipid-lowering medication users versus non-users: A real-world data analysis. J Clin Lipido. 2025;19:294\u2013302.","journal-title":"J Clin Lipido"},{"key":"2532_CR109","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41440-023-01267-1","volume":"46","author":"T Suenaga","year":"2023","unstructured":"Suenaga T, Satoh M, Murakami T, Hirose T, Obara T, Nakayama S, et al. Cross-classification by systolic and diastolic blood pressure levels and chronic kidney disease, proteinuria, or kidney function decline. Hypertens Res. 2023;46:1860\u20139.","journal-title":"Hypertens Res"},{"key":"2532_CR110","doi-asserted-by":"crossref","unstructured":"Kitaoka K, Kaneko H, Suzuki Y, Okada A, Mizuno A, Fujiu K, et al. Blood pressure control and treatment status at 1 year after the first health check-up in individuals with observed referral-level blood pressure. Hypertens Res. 2025;48:2537\u201347.","DOI":"10.1038\/s41440-025-02284-y"},{"key":"2532_CR111","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41440-024-01593-y","volume":"47","author":"Y Mori","year":"2024","unstructured":"Mori Y, Mizuno A, Fukuma S. Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study. Hypertens Res. 2024;47:1546\u201354.","journal-title":"Hypertens Res"},{"key":"2532_CR112","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s41440-024-01702-x","volume":"47","author":"Y Tabara","year":"2024","unstructured":"Tabara Y, Shoji-Asahina A, Ogawa A, Sato Y. Additive association of blood pressure and short stature with stroke incidence in 450,000 Japanese adults: the Shizuoka study. Hypertens Res. 2024;47:2075\u201385.","journal-title":"Hypertens Res"},{"key":"2532_CR113","doi-asserted-by":"crossref","unstructured":"Ito H, Seki T, Kawazoe Y, Takiguchi T, Akagi Y, Kubota K, et al. Prognostic impact of the timing of antihypertensive medication initiation for hypertension detected at health screening on primary prevention of adverse cardiovascular events: Age-stratified real-world data analysis. Hypertens Res. 2025;48:2401-12.","DOI":"10.1038\/s41440-025-02249-1"},{"key":"2532_CR114","doi-asserted-by":"crossref","unstructured":"Satoh M, Nobayashi H, Iwabe Y. Delayed treatment initiation as one of the crucial factors in clinical inertia: lessons from a real-world database research. Hypertens Res. 2025;48:2732\u20134.","DOI":"10.1038\/s41440-025-02320-x"},{"key":"2532_CR115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2307\/1293723","volume":"16","author":"GR McKinney","year":"1966","unstructured":"McKinney GR, Stavely HE. From Bench to Bedside: The Biologist in Drug Development. BioScience. 1966;16:683\u20137.","journal-title":"BioScience"},{"key":"2532_CR116","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41440-022-01134-5","volume":"46","author":"S Shibata","year":"2023","unstructured":"Shibata S, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, et al. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens Res. 2023;46:589\u2013600.","journal-title":"Hypertens Res"},{"key":"2532_CR117","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hernan","year":"2022","unstructured":"Hernan MA, Wang W, Leaf DE. Target Trial Emulation: A Framework for Causal Inference From Observational Data. JAMA. 2022;328:2446\u20137.","journal-title":"JAMA"},{"key":"2532_CR118","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hernan","year":"2016","unstructured":"Hernan MA, Robins JM. Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am J Epidemiol. 2016;183:758\u201364.","journal-title":"Am J Epidemiol"},{"key":"2532_CR119","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7143\/jhep.47.463","volume":"47","author":"T Watanabe","year":"2020","unstructured":"Watanabe T, Satoh H, Sugawara Y, Tsukita Y, Goto T, Kikuchi A. The Current State of Blood Pressure Measurement in Medical Examination Institutions \u2014A Study Based on Questionnaire Replies. Health Eval Promot. 2020;47:463\u20138.","journal-title":"Health Eval Promot"},{"key":"2532_CR120","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41440-021-00693-3","volume":"44","author":"K Kobayashi","year":"2021","unstructured":"Kobayashi K, Hatori N, Sakai H, Furuki T, Miyakawa M, Tamura K, et al. Comparison of questionnaire responses regarding awareness of Japanese Society of Hypertension guidelines for the management of hypertension between 2014 and 2019 in primary care. Hypertens Res. 2021;44:1147\u201357.","journal-title":"Hypertens Res"},{"key":"2532_CR121","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/s41440-024-01841-1","volume":"47","author":"N Chapman","year":"2024","unstructured":"Chapman N, Jayasinghe S, Moore MN, Picone DS, Schultz MG, Jose MD, et al. Absolute cardiovascular risk assessment using \u2018real world\u2019 clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational study. Hypertens Res. 2024;47:2855\u201363.","journal-title":"Hypertens Res"},{"key":"2532_CR122","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1038\/s41440-024-01817-1","volume":"47","author":"Q Yan","year":"2024","unstructured":"Yan Q, Cheng M, Xu W, Cheng Y, Wu F, Wang Y, et al. The control rate of hypertension across months of year and hours of day in a large real-world database. Hypertens Res. 2024;47:2981\u20138.","journal-title":"Hypertens Res"},{"key":"2532_CR123","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008509","volume":"7","author":"T Hanazawa","year":"2018","unstructured":"Hanazawa T, Asayama K, Watabe D, Tanabe A, Satoh M, Inoue R, et al. Association Between Amplitude of Seasonal Variation in Self-Measured Home Blood Pressure and Cardiovascular Outcomes: HOMED-BP (Hypertension Objective Treatment Based on Measurement By Electrical Devices of Blood Pressure) Study. J Am Heart Assoc. 2018;7:e008509.","journal-title":"J Am Heart Assoc"},{"key":"2532_CR124","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/hr.2016.133","volume":"40","author":"T Hanazawa","year":"2017","unstructured":"Hanazawa T, Asayama K, Watabe D, Hosaka M, Satoh M, Yasui D, et al. Seasonal variation in self-measured home blood pressure among patients on antihypertensive medications: HOMED-BP study. Hypertens Res. 2017;40:284\u201390.","journal-title":"Hypertens Res"},{"key":"2532_CR125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2013.08.042","volume":"113","author":"L Liu","year":"2014","unstructured":"Liu L, Miura K, Fujiyoshi A, Kadota A, Miyagawa N, Nakamura Y, et al. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan. Am J Cardiol. 2014;113:84\u201389.","journal-title":"Am J Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02532-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:02:09Z","timestamp":1772665329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02532-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":125,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02532-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MS received academic support from Bayer Yakuhin Co., Ltd., and a grant from the Kowa Life Science Foundation funded by Kowa Co., Ltd. HM concurrently holds the position of Director of the Tohoku Institute for the Management of Blood Pressure, supported by Omron Healthcare Co., Ltd. We previously obtained access to the databases of the Japan Health Insurance Association (JHIA), JMDC Inc., and DeSC Healthcare, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}